Company Tagline
Pioneering advanced nanocarrier-based radioligand therapy for aggressive brain cancer.
Industry Category
Business Keywords
Company Description
GlioRay is a pioneering pharmaceutical manufacturing company dedicated to revolutionizing cancer treatment through innovative nanocarrier-based radioligand therapy. Located in Copenhagen, Capital Region of Denmark, GlioRay is committed to developing life-saving therapies for glioblastoma, one of the most aggressive forms of brain cancer. GlioRay’s mission is to transform cancer treatment, offering new hope and extending lives through cutting-edge science.
GlioRay’s proprietary technology integrates the latest advancements in nanocarriers and Auger radioligand therapy. This unique approach involves designing nanoscale carriers that deliver radioactive isotopes directly to cancer cells using convection-enhanced delivery. This delivery system increases the efficacy of the treatment while reducing side effects, offering a more effective and patient-friendly solution. The primary address of GlioRay is Copenhagen, Capital Region of Denmark 2200, DK.
GlioRay is driven by a vision to target cancer cells with unprecedented precision, minimizing damage to surrounding healthy tissue and maximizing therapeutic outcomes. With a focus on innovation and collaboration, GlioRay is dedicated to pushing the boundaries of what is possible in cancer treatment, bringing groundbreaking therapies from the lab to the clinic. The information about GlioRay will be completed soon with the support of the company’s management.
To the manager of GlioRay: We invite you to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial development.
GlioRay er en banebrydende farmaceutisk produktionsvirksomhed, der er dedikeret til at revolutionere kræftbehandling gennem innovativ nanobærerbaseret radioligandterapi. Beliggende i København, Region Hovedstaden, Danmark, er GlioRay engageret i at udvikle livreddende terapier til glioblastom, en af de mest aggressive former for hjernekræft. GlioRays mission er at transformere kræftbehandling og tilbyde nyt håb og forlænge liv gennem banebrydende videnskab.
GlioRays proprietære teknologi integrerer de seneste fremskridt inden for nanobærere og Auger radioligandterapi. Denne unikke tilgang involverer design af nanoskala-bærere, der leverer radioaktive isotoper direkte til kræftceller ved hjælp af konvektionsforstærket levering. Dette leveringssystem øger behandlingens effektivitet og reducerer samtidig bivirkninger, hvilket giver en mere effektiv og patientvenlig løsning. GlioRays primære adresse er København, Region Hovedstaden 2200, DK.
GlioRay er drevet af en vision om at målrette kræftceller med hidtil uset præcision, minimere skader på omgivende sundt væv og maksimere terapeutiske resultater. Med fokus på innovation og samarbejde er GlioRay dedikeret til at flytte grænserne for, hvad der er muligt inden for kræftbehandling, og bringe banebrydende terapier fra laboratoriet til klinikken. Informationen om GlioRay vil snart blive færdiggjort med støtte fra virksomhedens ledelse.
Til lederen af GlioRay: Vi inviterer dig til at oprette en tilpasset og eksklusiv virksomhedspræsentation og produktliste på vores platform for yderligere at forbedre din kommercielle udvikling.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
CODE Purple
Pharmaceutical-ManufacturingProvide Business Development Services Primarily in Healthcare but also Media, Local Government and S...
PHARMACEUTECH R&D
Pharmaceutical-ManufacturingInnovation for Health, Solutions for Life.
A2 Healthcare Corporation
Pharmaceutical-ManufacturingGlobal Clinical CRO operating in the US/Japan/Taiwan Winner of "Citeline PharmaIntelligence Award 20...
Galimedix Therapeutics, Inc.
Pharmaceutical-ManufacturingDeveloping novel neuroprotective drugs to treat the leading causes of blindness and Alzheimer’s dise...
Alternative Company Names
This company is also known as